Alpa Laboratories quarterly results and financials

Alpa Laboratories (ALPA)₹56.58+1.16%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Alpa Laboratories reported sales of ₹23.90 Cr, up 25.3% from Jun 2025, and net profit of ₹0.99 Cr, down 91.6% year on year. For the year to Mar 2026, sales were ₹106 Cr and net profit ₹15.06 Cr.

Sales (Jun 2026): ₹23.90 Cr
Net profit (Jun 2026): ₹0.99 Cr
Sales (FY Mar 2026): ₹106 Cr
Net profit (FY Mar 2026): ₹15.06 Cr
EPS (Jun 2026): ₹0.48
Borrowings (Mar 2026): ₹3 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Alpa Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Alpa Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	32.32	27.24	23.57	21.39	24.91	26.12	39.85	19.08	26.20	29.00	31.34	23.90
Expenses	29.10	24.91	20.15	20.95	21.68	25.45	39.81	18.71	28.56	27.58	27.84	27.95
Operating Profit	3.36	2.44	3.52	0.54	3.33	0.75	0.21	0.44	−2.26	1.52	3.61	−3.97
OPM %	10.3%	8.9%	14.9%	2.5%	13.3%	2.8%	0.5%	2.2%	−8.6%	5.2%	11.4%	−16.6%
Other Income	2.94	3.54	3.97	5.14	6.88	8.77	2.47	11.89	3.05	0.90	−0.15	5.75
Interest	0.03	0.03	0.30	0.06	0.06	0.10	0.03	0.06	0.04	0.04	0.16	0.12
Depreciation	0.50	0.67	0.53	0.55	0.54	0.56	0.59	0.56	0.68	0.66	0.23	0.73
Profit before tax	5.77	5.28	6.65	5.08	9.61	8.87	2.07	11.72	0.10	1.73	3.06	0.97
Tax %	0.0%	14.9%	46.6%	0.0%	20.3%	0.0%	201.8%	0.0%	0.0%	9.2%	55.0%	0.0%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	5.81	4.52	3.56	5.11	7.72	8.93	−2.13	11.82	0.12	1.60	1.39	0.99
EPS (Rs)	2.76	2.15	1.70	2.43	3.66	4.24	−1.02	5.61	0.06	0.77	0.67	0.48

Alpa Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Alpa Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	52.94	62.89	61.91	76.83	84.82	96.91	112	92.86	109	110	106	110
Expenses	47.12	56.11	58.11	76.19	80.14	90.16	101	85.21	100	105	103	112
Operating Profit	7.01	7.01	4.01	1.01	6.02	8.02	11.03	8.02	9.02	5.01	3.01	−1.10
OPM %	13.0%	11.0%	7.0%	1.5%	7.0%	8.0%	10.0%	9.0%	8.0%	4.4%	3.1%	−1.0%
Other Income	4.98	2.99	4.98	4.98	0.00	3.98	10.96	8.96	13.96	22.91	15.95	9.55
Interest	1.01	2.01	1.01	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.36
Depreciation	1.01	3.01	3.01	3.01	3.01	1.01	2.01	1.01	2.01	2.01	2.01	2.30
Profit before tax	9.96	5.98	4.98	2.99	2.99	10.96	19.92	15.93	20.92	25.89	16.94	5.86
Tax %	30.0%	54.9%	38.9%	63.0%	35.9%	32.9%	28.0%	20.9%	18.9%	23.9%	10.0%	—
Exceptional items	0.00	−0.68	−0.12	0.15	−0.80	2.07	6.40	−0.02	−0.44	−0.05	0.00	0.00
Net Profit	7.02	3.01	3.01	1.01	2.01	7.02	14.06	13.04	17.04	20.08	15.06	4.10
EPS (Rs)	3.27	1.21	1.35	0.49	0.89	3.46	6.72	6.00	8.01	9.30	7.15	1.98
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Alpa Laboratories balance sheet

₹ crore, at each year end.

Alpa Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	20.97	21.01	21.00	20.99	20.99	21.00	20.99	20.99	20.98	20.99	20.99	21.00
Reserves	65.92	72.00	73.92	76.99	76.90	78.89	86.91	101	114	131	150	165
Borrowings	28.97	24.02	11.00	6.00	2.00	0.00	0.00	6.00	2.00	4.99	0.00	3.00
Other Liabilities	12.95	26.86	19.91	17.92	20.90	20.90	32.84	27.86	29.85	24.88	50.75	52.74
Total Liabilities	128	144	126	122	121	121	140	155	167	182	223	242
Fixed Assets	5.02	15.06	15.05	10.04	8.03	6.02	7.03	9.04	7.03	11.04	21.07	20.07
CWIP	0.00	0.00	0.00	0.00	0.00	1.01	2.01	0.00	0.00	0.00	0.00	0.00
Investments	9.99	11.99	12.99	30.97	48.91	56.88	50.94	74.89	77.85	97.82	118	142
Other Assets	113	118	96.79	80.89	64.85	57.88	80.76	70.81	81.78	72.83	83.81	79.83
Inventories	7.53	15.02	13.05	13.73	14.05	12.56	16.58	15.47	12.66	13.69	17.65	13.34
Trade receivables	24.58	34.47	29.28	26.11	30.09	24.66	35.57	38.20	46.94	41.32	47.02	40.96
Cash & equivalents	72.11	36.62	36.63	21.33	0.89	6.16	10.49	1.57	8.80	1.70	2.21	2.83
Total Assets	128	144	126	122	121	121	140	155	167	182	223	242

Alpa Laboratories cash flow

₹ crore, for each year.

Alpa Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−2.01	−22.03	17.02	−13.01	−1.01	18.03	−2.01	10.01	9.01	4.01	18.01	10.01
Cash from investing activity	36.86	−7.97	−1.99	−10.97	−14.95	−10.96	5.98	−15.94	1.99	−12.96	−11.95	−11.96
Cash from financing activity	7.01	−6.01	−15.03	9.01	−5.01	−1.01	0.00	5.01	−4.01	3.01	−5.01	2.01
Net cash flow	42.06	−36.05	0.00	−15.03	−20.04	5.01	4.01	0.00	7.01	−7.01	1.01	1.01
Capex	1.18	0.00	1.42	1.98	0.86	2.56	3.23	2.20	1.14	6.40	11.40	3.96
Free cash flow	−3.01	−31.98	16.01	−14.98	−1.99	14.99	−4.99	8.01	7.99	−3.01	6.99	5.99
CFO / OP %	−92.0%	−277.1%	283.0%	−263.1%	101.9%	324.0%	15.0%	123.0%	154.9%	85.0%	466.0%	389.0%

Alpa Laboratories ratios

Working-capital days and returns, by year.

Alpa Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	155	233	167	152	141	104	132	123	183	137	154	140
Inventory days	77	197	132	139	106	91	103	82	85	74	93	74
Days payable	92	245	141	135	100	99	153	79	101	64	98	99
Cash conversion cycle	140	186	158	156	148	96	82	126	167	148	149	115
Working capital days	−4	205	175	209	195	126	141	119	153	136	111	538
ROCE %	0.0%	10.1%	8.1%	6.0%	3.0%	5.0%	7.0%	9.1%	12.1%	15.1%	16.1%	9.1%

Alpa Laboratories: frequently asked questions

What are the latest quarterly results of Alpa Laboratories?

For the Jun 2026 quarter, Alpa Laboratories reported sales of ₹23.90 Cr, up 25.3% year on year and net profit of ₹0.99 Cr, down 91.6% year on year. The operating margin was −16.6%.

What is the annual revenue of Alpa Laboratories?

Alpa Laboratories' sales for the year to Mar 2026 were ₹106 Cr; over the last twelve months they were ₹110 Cr.

What is the net profit of Alpa Laboratories?

Net profit for the year to Mar 2026 was ₹15.06 Cr, and ₹4.10 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.98.

How much debt does Alpa Laboratories have?

Alpa Laboratories reported borrowings of ₹3 Cr at Mar 2026, against cash and equivalents of ₹2.83 Cr.

What is the free cash flow of Alpa Laboratories?

Cash from operations was ₹10.01 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.99 Cr.

Loading…